期刊文献+

人干细胞因子模拟肽与c-JUN亮氨酸拉链融合蛋白的原核表达和生物学功能鉴定 被引量:1

Expression of Human Stem Cell Factor Mimetic Peptides Fused with c-jun Leucine Zipper in E. coli and Identification of Its Bio-activity
原文传递
导出
摘要 将两种人干细胞因子(hSCF)模拟肽(CS2和LS2)分别与c-jun亮氨酸拉链在大肠杆菌中融合表达,比较模拟肽与融合蛋白的生物学活性。通过搭桥PCR的方法,构建分别含有CS2和LS2与c-jun亮氨酸拉链融合蛋白及单独c-jun亮氨酸拉链编码序列的三种原核表达质粒pET30a-CSJ,pET30a-LSJ和pET30a-Jun,在E.coli BL21中进行表达,经镍柱和Sephadex G-50柱纯化后,SDS-PAGE和质谱法检测重组融合蛋白(CSJ,LSJ)和c-Jun的理化性质,MTT法检测融合蛋白刺激UT-7细胞增殖的活性。结果显示CSJ,LSJ和c-jun在E.coli中均呈20%左右表达,经纯化后其纯度达95%以上,分子量分别为7336.08,7991.54和6672.74。细胞学活性实验显示:与CS2和LS2相比,CSJ和LSJ促进UT-7细胞增殖的活性提高约1000倍。在大肠杆菌中成功表达了hSCF模拟肽与c-jun亮氨酸拉链融合蛋白,融合蛋白活性显著高于合成的hSCF模拟肽。 The two human stem cell factor(hSCF)mimetic peptides(CS2 and LS2)fused with the c-jun leucine zipper respectively were expressed in E.coli and the bio-activity of the fusion proteins was identified.The three expression plasmids pET30a-CSJ,pET30a-LSJ and pET30a-Jun,which contain fusion proteins(CSJ and LSJ)and c-jun gene respectively,were constructed by using overlapping PCR.Results showed that the CSJ,LSJ and c-Jun(CJ)were expressed about 20% of total protein in E.coli BL21.After purified by using affinity Ni-NTA and Sephadex G-50 column chromatography,the purity of the CSJ,LSJ and CJ were over 95% identified by using SDS-PAGE analysis.Their molecular mass was 7336.0 8,7991.54 and 6672.74 respectively determined by mass spectrometry.The bioactivity of the fusion proteins was evaluated by using cell proliferation assay with MTT in UT-7 cell.Compared to CS2 and LS2,the bioactivities of CSJ and LSJ were dramatically improved and it is about 1000 fold higher than that of CS2 and LS2.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2010年第12期5-9,共5页 China Biotechnology
基金 国家"863"计划重大专项基金(2003AAZ3360)资助项目
关键词 人干细胞因子 模拟肽 融合蛋白 亮氨酸拉链 Human stem cell factor Mimetic peptide Fusion protein Leucine zipper
  • 相关文献

参考文献17

  • 1Broudv V C. Stem cell factor and hematopoiesis. Blood, 1997, 90 : 1345 -1364.
  • 2Ashman I. K. The biology of stem cell factor and its receptor c- kit. Int J Biochem Cell& Boil,1999, 31:1037-1051.
  • 3Yazawa S, Opatowsky Y, Zhang Z, et al. Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor. Cell, 2007, 130:213-215.
  • 4Glaspy J, Davis M W , Parker W R L. Biology and clinical potential of stem cell factor. Canncer Chemother Pharrncol, 1996, 38(suppl) :553 -557.
  • 5Glaiy J A, Shpall E T, Lemaistre C F, et al. Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in high-risk breat cancer patients. Blood, 1997, 90 : 2939-2943.
  • 6Xiang F L, Lu X, Hammoud L, et al. Cardiomyocyte-specific overcxpression of human stem cell improves cardiac function and survival after myocardial infarction in mice. Circulation, 2009, 120:1065 -1074.
  • 7Basset R L, Begley C G , Maher D, et al. Rapid hematoietic recovery after multicycle high-dose chemotherapy : enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem cell factor. J Clin Oncol, 1998,16(5) :1899-1908.
  • 8Shpall E J, Wheeler C A, Turner S A. A randomsed phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients. Blood, 1999,93(8) :2491-2501.
  • 9苏林,刘长征,邓艳春,杨克恭,梁植权,陈松森.人干细胞因子受体膜外区1~3免疫球蛋白样结构域的表达、纯化及活性[J].中国医学科学院学报,2006,28(2):154-158. 被引量:2
  • 10Giehel L B, Cass R T, Milligan D L, et al. Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities. Biochemistry, 1995, 34 : 15430-15435.

二级参考文献13

  • 1李川晟,程涛,许燕群.重组人干细胞因子对放射病患者造血细胞的体外作用[J].中华放射医学与防护杂志,1994,14(4):221-224. 被引量:8
  • 2王亚栋,张艳丽,杨克恭,邓艳春,苏林,罗丝,刘长征,陈松森.携带人FL、GM-CSF基因的裸DNA的抑瘤作用[J].基础医学与临床,2005,25(10):914-919. 被引量:2
  • 3Blechman JM,Lev S,Brizzi MF,et al.Soluble c-kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor.J Biol Chem,1993,268 (6):4399-4406.
  • 4Dahlen DD,Lin NL,Liu YC,et al.Soluble Kit receptor blocks stem cell factor bioactivity in vitro.Leuk Res,2001,25(5):413-421.
  • 5Nakamura Y,Tajima F,Ishiga K,et al.Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice.Exp Hematol,2004,32(4):390-396.
  • 6Takeshima H,Kuratsu J.A review of soluble c-kit (s-kit) as a novel tumor marker and possible molecular target for the treatment of CNS germinoma.Surg Neurol,2003,60 (4):321-324.
  • 7Novokhatny V,Medved L,Lijnen HR,et al.Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site.An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.J Biol Chem,1995,270(15):8680-8685.
  • 8Ishibashi M,Tokunaga H,Arakawa T,et al.Expression,purification,and characterization of the active immunoglobulinlike domain of human granulocyte-colony-stimulating factor receptor in Escherichia coli.Protein Expr Purif,2001,21 (2):317-322.
  • 9Singh SM,Panda AK.Solubilization and refolding of bacterial inclusion body proteins.J Biosci Bioeng,2005,99 (4):303-310.
  • 10Jungbauer A,Kaar W,Schlegl R.Folding and refolding of proteins in chromatographic beds.Curr Opin Biotechnol,2004,15(5):487-494.

共引文献4

同被引文献43

  • 1金璐,赵玉伟,李知勉,赵成建,王晓飞,张凌,杨寒朔.真核表达人和鼠可溶性VEGFR2的双基因疫苗的构建及抗肿瘤实验研究[J].四川大学学报(医学版),2010,41(4):563-566. 被引量:3
  • 2和祯泉,刘天健,吕英军,鲍恩东.抗菌肽Folicidin-3在大肠杆菌中融合表达及抑菌活性[J].扬州大学学报(农业与生命科学版),2011,32(4):1-6. 被引量:6
  • 3陈曦,孙国军,赵文静,焦健,刘松涛,梁冰,刘双燕.自体骨髓干细胞治疗终末期肝病24例临床观察[J].临床肝胆病杂志,2012,28(1):55-57. 被引量:6
  • 4吴梧桐.生化与生物技术药物的研发现状与发展方向[R].2012’中国生物药物创新研究论坛-酶类药物的研究与开发论文集.2012.
  • 5Huggett B, Hodgson J, Lhteenmki R. Public Biotech 2010- the numbers [ J]. Nature Biotechnology ,2011,29 :585.
  • 6邓洪民,张靖溥.2010年我国重组细胞因子药物研究进展[R].中国药学年鉴,2011,57.
  • 7李谦,王友同.2009年我国生物技术药物研究进展[R].中国药学年鉴,2010,43.
  • 8刘芳君,郝海峰,王冬梅,等.融合蛋白GST-hRI糖尿病性白内障模型大鼠晶状体浑浊程度的改善作用研究[J].中国药学,2011,22(5):395.
  • 9Zhou JJ, Chen ML, Zhang QZ. Blocking gastrin and CCK-B autoc- sine loop affects cell proliferation and apoptosis in vitro [ J ]. Mol Cell Biochem,2010,343 ( 1-2 ) : 133.
  • 10Pang JC, Li KK, Lau KM, et al. KIAA 0495/PDAM Is frequantly downregulated in oligodendroglial tumors and its Knockdown by siRNA iduces cisplatin resistance in Glioma Cell [ J ]. Brain Pathol,2010 ,20( 6 ) :1021.

引证文献1

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部